Investigation of the Safety and Efficacy of Eszopiclone in Insomnia Patients

Eisai

Status: Completed

Conditions: Insomnia

Treatments: Drug: Eszopiclone

Study type: Observational

Funder types: Industry

Identifiers

NCT02452684

LUN01S

Details and patient eligibility

About

To investigate the safety and efficacy of administration of eszopiclone for 4 weeks in insomnia patients.

Enrollment: 4,876 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

1. Insomnia participants who did not take eszopiclone before assessment
2. Participants who receive assessment by using sleep questionaries

Trial design

4,876 participants in 1 patient group

Participants with insomnia

Description:

Participants with insomnia who will receive eszopiclone, per approved label.

Treatment:

Drug: Eszopiclone